[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
IJRR Information::
About the Journal
Editorial Board
Keywords
For Authors::
Aims and Scope
Call for Papers
Submission Instructions
For Reviewers::
Referee page
Subscription::
Subscription Form
News & Events::
Journal News
Web Mail::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
ISSN
Hard Copy 2322-3243
Online 2345-4229
..
Online Submission
Now you can send your articles to IJRR office using the article submission system.
..

AWT IMAGE

AWT IMAGE
:: Volume 23, Issue 2 (5-2025) ::
Int J Radiat Res 2025, 23(2): 317-327 Back to browse issues page
Correlation identification between radiotracer uptake and pathological features in non-small cell lung cancer (NSCLC)
Y. Sheng , R. Zhou
Pulmonary and Critical Care Medicine, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Zhejiang, China
Abstract:   (471 Views)
Background: SUV values from PET/CT can reflect disease progression; however, there are few detailed and comprehensive studies. In this study, we hope to provide data to complement the analysis of diagnostic indicators for NSCLC, LUAD, and LUSC by analyzing the correlation between SUVmax and various pathological parameters. Patients and Methods: Patients (n=298) with lung lesions were retrospectively studied and clinicopathological index of these patients were collected. Radiomics texture features were extracted by PET/CT scanning and histological features of each patient was collected. The values of SUVmax were obtained and the inner correlation was analyzed. Evaluation and scoring were performed by calculating area under the curve (AUC), sensitivity, specificity and accuracy. Results: PET data were counted and analyzed for positive/negative relationship between SUV value and T stage and histology (P<0.05). Mean SUVmax was 13.32±6.41 mm; the SUVmax was 14.01±5.72 for male and 11.19±7.95 for female. The results showed that LUSC tumors were smaller and more homogeneous, but with more uptake and greater PET variability. In contrast, LUAD have lower and weaker uptake, variability and homogeneity. Conclusion: By meticulously grouping nearly 300 NSCLC samples, AUC values were calculated to indicate the diagnostic value in NSCLC, LUAD and LUSC. It provides ideas and basis for pathological staging analysis of NSCLC.
Keywords: Non-small cell lung cancer (NSCLC), neoplasm histological type, 18F-FDG, area under curves (AUC), diagnose.
Full-Text [PDF 1512 kb]   (103 Downloads)    
Type of Study: Original Research | Subject: Radiation Biology
References
1. Bray F, Laversanne M, Sung H, et al. (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 74(3): 229-263. [DOI:10.3322/caac.21834]
2. Kratzer TB, Bandi P, Freedman ND, et al. (2024) Lung cancer statistics, 2023. Cancer, 130(8): 1330-1348. [DOI:10.1002/cncr.35128]
3. Leiter A, Veluswamy RR, Wisnivesky JP (2023) The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol, 20(9): 624-639. [DOI:10.1038/s41571-023-00798-3]
4. Lee E and Kazerooni EA (2022) Lung cancer screening. Semin Respir Crit Care Med, 43(6): 839-850. [DOI:10.1055/s-0042-1757885]
5. Wu F, Wang L, Zhou C (2021) Lung cancer in China: current and prospect. Curr Opin Oncol, 33(1): 40-46. [DOI:10.1097/CCO.0000000000000703]
6. Sugai Y, Kadoya N, Tanaka S, et al. (2021) Impact of feature selection methods and subgroup factors on prognostic analysis with CT-based radiomics in non-small cell lung cancer patients. Radiat Oncol, 16(1): 80. [DOI:10.1186/s13014-021-01810-9]
7. Wang BY, Huang JY, Chen HC, et al. (2020) The comparison between adenocarcinoma and squamous cell carcinoma in lung cancer patients. J Cancer Res Clin Oncol, 146(1): 43-52. [DOI:10.1007/s00432-019-03079-8]
8. Kalemaki MS, Karantanas AH, Exarchos D, et al. (2020) PET/CT and PET/MRI in ophthalmic oncology (Review). Int J Oncol, 56(2): 417-429. [DOI:10.3892/ijo.2020.4955]
9. Zangeneh M, Nedaei HA, Mozdarani H, et al. (2019) Enhanced cytotoxic and genotoxic effects of gadolinium-doped ZnO nanoparticles on irradiated lung cancer cells at megavoltage radiation energies. Mater Sci Eng C Mater Biol Appl, 103: 109739. [DOI:10.1016/j.msec.2019.109739]
10. Zhang X, Zhang G, Qiu X, et al. (2024) Exploring non-invasive precision treatment in non-small cell lung cancer patients through deep learning radiomics across imaging features and molecular phenotypes. Biomark Res, 12(1): 12. [DOI:10.1186/s40364-024-00561-5]
11. Schillaci O, Scimeca M, Toschi N, et al. (2019) Combining Diagnostic Imaging and Pathology for Improving Diagnosis and Prognosis of Cancer. Contrast Media Mol Imaging. 2019: 9429761. [DOI:10.1155/2019/9429761]
12. Otani T, Ikushima H, Bando Y, et al. (2023) Early prediction of radiotherapeutic efficacy in a mouse model of non-small cell lung carcinoma using 18F-FLT and 18F-FDG PET/CT. J Med Invest, 70(3.4): 361-368. [DOI:10.2152/jmi.70.361]
13. Kagimoto A, Tsutani Y, Mimae T, et al. (2022) Segmentectomy versus lobectomy for solid predominant cN0 lung cancer: analysis using visual evaluation of positron emission tomography. Eur J Cardiothorac Surg, 61(2): 279-286. [DOI:10.1093/ejcts/ezab434]
14. Cegla P, Bryl M, Witkowska K, et al. (2021) Differences between TNM classification and 2-[18F]FDG PET parameters of primary tumor in NSCLC patients. Rep Pract Oncol Radiother, 26(3): 445-450. [DOI:10.5603/RPOR.a2021.0072]
15. Pirayesh E, Amoui M, Akhlaghpoor S, et al. (2014) Technical Considerations of Phosphorous-32 Bremsstrahlung SPECT Imaging after Radioembolization of Hepatic Tumors: A Clinical Assessment with a Review of Imaging Parameters. Radiol Res Pract, 2014: 407158. [DOI:10.1155/2014/407158]
16. Lee J, Li B, Cui Y, et al. (2018) A quantitative CT imaging signature predicts survival and complements established prognosticators in stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys, 102(4): 1098-1106. [DOI:10.1016/j.ijrobp.2018.01.006]
17. Han Y, Dong Z, Xing Y, et al. (2023) Establishment of a prognosis prediction model for lung squamous cell carcinoma related to PET/CT: basing on immunogenic cell death-related lncRNA. BMC Pulm Med, 23(1): 511. [DOI:10.1186/s12890-023-02792-y]
18. Mozdarani H (2012) Biological complexities in radiation carcinogenesis and cancer radiotherapy: impact of new biological paradigms. Genes (Basel), 3(1): 90-114. [DOI:10.3390/genes3010090]
19. Liang L, Zhang H, Lei H, et al. (2022) Diagnosis of benign and malignant pulmonary ground-glass nodules using computed tomography radiomics parameters. Technol Cancer Res Treat, 21: 15330338221119748. [DOI:10.1177/15330338221119748]
20. Kadoya N, Tanaka S, Kajikawa T, et al. (2020) Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomics. Med Phys, 47(5): 2197-2205. [DOI:10.1002/mp.14104]
21. Wang R, Dai W, Gong J, et al. (2022) Development of a novel combined nomogram model integrating deep learning-pathomics, radiomics and immunoscore to predict postoperative outcome of colorectal cancer lung metastasis patients. J Hematol Oncol, 15(1): 11. [DOI:10.1186/s13045-022-01225-3]
22. Pfaehler E, Mesotten L, Zhovannik I, et al. (2021) Plausibility and redundancy analysis to select FDG-PET textural features in non-small cell lung cancer. Med Phys, 48(3): 1226-1238. [DOI:10.1002/mp.14684]
23. Boellaard R, Delgado-Bolton R, Oyen WJ, et al. (2015) FDG PET/CT: EANM procedure guidelines for tumor imaging: version 2.0. Eur J Nucl Med Mol Imaging, 42(2): 328-54. [DOI:10.1007/s00259-014-2961-x]
24. Zhou R, Cai Z, Yuan Y, et al. (2024) Study on the application value of combined detection of multiple tumor markers in lung cancer classification diagnosis. Int J Radiat Res, 22 (2): 283-287. [DOI:10.61186/ijrr.22.2.283]
25. Chetan MR and Gleeson FV (2021) Radiomics in predicting treatment response in non-small-cell lung cancer: current status, challenges and future perspectives. Eur Radiol, 31(2): 1049-1058. [DOI:10.1007/s00330-020-07141-9]
26. Deng J, Ren W, Shen J, et al. (2024) Maximum PET/CT 18F-FDG uptake of lymph nodes predict prognosis in esophageal squamous cell carcinoma. Int J Radiat Res, 22 (2): 265-270. [DOI:10.61186/ijrr.22.2.265]
27. Pang Y, Zhao L, Meng T, et al. (2023) PET imaging of fibroblast activation protein in various types of cancer using 68Ga-FAP-2286: Comparison with 18F-FDG and 68Ga-FAPI-46 in a single-center, prospective study. J Nucl Med, 64(3): 386-394. [DOI:10.2967/jnumed.122.264544]
28. Liao S, Penney BC, Wroblewski K, et al. (2012) Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging, 39(1): 27-38. [DOI:10.1007/s00259-011-1934-6]
29. Chen X, Shen L, Hong Y (2023) 18F-fluorodeoxyglucose positron emission tomography/computed tomography for predicting prognosis of small cell lung cancer patients. Int J Radiat Res, 21(2): 211-215.
30. Hicks RJ. (2022) The Value of the standardized uptake value (SUV) and metabolic tumor volume (MTV) in lung cancer. Semin Nucl Med, 52(6): 734-744. [DOI:10.1053/j.semnuclmed.2022.04.007]
31. Rogasch JMM, Furth C, Chibolela C, et al. (2020) Validation of independent prognostic value of asphericity of 18F-fluorodeoxyglucose uptake in non-small-cell lung cancer patients undergoing treatment with curative intent. Clin Lung Cancer, 21(3): 264-272.e6. [DOI:10.1016/j.cllc.2019.10.001]
32. Pyka T, Bundschuh RA, Andratschke N, et al. (2015) Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early-stage NSCLC patients receiving primary stereotactic radiation therapy. Radiat Oncol, 10: 100. [DOI:10.1186/s13014-015-0407-7]
33. Mallorie A, Goldring J, Patel A, et al. (2017) Assessment of nodal involvement in non-small-cell lung cancer with 18F-FDG-PET/CT: mediastinal blood pool cut-off has the highest sensitivity and tumor SUVmax/2 has the highest specificity. Nucl Med Commun, 38(8): 715-719. [DOI:10.1097/MNM.0000000000000703]
34. Casali C, Cucca M, Rossi G, et al. (2010) The variation of prognostic significance of Maximum Standardized Uptake Value of [18F]-fluoro-2-deoxy-glucose positron emission tomography in different histological subtypes and pathological stages of surgically resected Non-Small Cell Lung Carcinoma. Lung Cancer, 69(2): 187-93. [DOI:10.1016/j.lungcan.2009.10.015]
35. Zengin T and Önal-Süzek T (2021) Comprehensive profiling of genomic and transcriptomic differences between risk groups of lung adenocarcinoma and lung squamous cell carcinoma. J Pers Med, 11(2): 154. [DOI:10.3390/jpm11020154]
36. Li J, Ge S, Sang S, et al. (2021) Evaluation of PD-L1 expression level in patients with non-small cell lung cancer by 18F-FDG PET/CT radiomics and clinicopathological characteristics. Front Oncol, 11: 789014. [DOI:10.3389/fonc.2021.789014]
Add your comments about this article
Your username or Email:

CAPTCHA

XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Sheng Y, Zhou R. Correlation identification between radiotracer uptake and pathological features in non-small cell lung cancer (NSCLC). Int J Radiat Res 2025; 23 (2) :317-327
URL: http://ijrr.com/article-1-6312-en.html
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 23, Issue 2 (5-2025) Back to browse issues page
International Journal of Radiation Research
Persian site map - English site map - Created in 0.08 seconds with 50 queries by YEKTAWEB 4714